Alekhya Lavu1, Christine Vaccaro1, Walid Shouman1, Silvia Alessi Severini1, Sherif Eltonsy2. 1. College of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada. 2. College of Pharmacy, University of Manitoba, 750 McDermot Ave W, Winnipeg, MB, R3E 0T5, Canada. sherif.eltonsy@umanitoba.ca.
Abstract
BACKGROUND: The prevalence of epilepsy in pregnant women is estimated at 0.3-1%. Anti-epileptic drug (AED) exposure in-utero has been associated with various adverse health outcomes in neonates, including adverse birth weight outcomes. OBJECTIVE: This review aims to summarize the published evidence on the association between AED exposure in pregnancy and adverse birth weight outcomes METHODS: Studies assessing AED exposure in pregnancy and neonatal birth weight outcomes, including small for gestational age (SGA), low birth weight (LBW), birth weight (BW), length, head circumference, and cephalization index will be identified in MEDLINE®, EMBASE, Cochrane Library, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), International Pharmaceutical Abstracts (IPA), and Global Health. Open grey, Theses Canada, and ProQuest Dissertations will be used to locate gray literature. Eligible study designs will include both intervention and non-interventional studies. We will not impose any time limit in the review. We will use the Newcastle-Ottawa Scale to assess the methodological quality of observational studies and quasi-experimental studies included in the review. The risk of bias of experimental studies will be appraised using the Cochrane risk-of-bias tool for randomized trials (RoB 2). A meta-analysis will be conducted using a random-effects model. DISCUSSION: The results from this review could improve clinicians' prescribing decisions by highlighting the safest AEDs for women who are pregnant or planning to conceive based on the evidence currently available. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020192713.
BACKGROUND: The prevalence of epilepsy in pregnant women is estimated at 0.3-1%. Anti-epileptic drug (AED) exposure in-utero has been associated with various adverse health outcomes in neonates, including adverse birth weight outcomes. OBJECTIVE: This review aims to summarize the published evidence on the association between AED exposure in pregnancy and adverse birth weight outcomes METHODS: Studies assessing AED exposure in pregnancy and neonatal birth weight outcomes, including small for gestational age (SGA), low birth weight (LBW), birth weight (BW), length, head circumference, and cephalization index will be identified in MEDLINE®, EMBASE, Cochrane Library, Scopus, Cumulative Index of Nursing and Allied Health Literature (CINAHL), International Pharmaceutical Abstracts (IPA), and Global Health. Open grey, Theses Canada, and ProQuest Dissertations will be used to locate gray literature. Eligible study designs will include both intervention and non-interventional studies. We will not impose any time limit in the review. We will use the Newcastle-Ottawa Scale to assess the methodological quality of observational studies and quasi-experimental studies included in the review. The risk of bias of experimental studies will be appraised using the Cochrane risk-of-bias tool for randomized trials (RoB 2). A meta-analysis will be conducted using a random-effects model. DISCUSSION: The results from this review could improve clinicians' prescribing decisions by highlighting the safest AEDs for women who are pregnant or planning to conceive based on the evidence currently available. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020192713.
Entities:
Keywords:
Anti-epileptic drugs; Birth weight outcomes; Epilepsy; Low birth weight; Small for gestational age
Authors: K Pilgaard; K Færch; B Carstensen; P Poulsen; C Pisinger; O Pedersen; D R Witte; T Hansen; T Jørgensen; A Vaag Journal: Diabetologia Date: 2010-09-22 Impact factor: 10.122
Authors: Sonia Hernández-Díaz; Thomas F McElrath; Page B Pennell; W Allen Hauser; Mark Yerby; Lewis B Holmes Journal: Ann Neurol Date: 2017-09 Impact factor: 10.422
Authors: P B Pennell; A M Klein; N Browning; G A Baker; J Clayton-Smith; L A Kalayjian; J D Liporace; M Privitera; T Crawford; D W Loring; K J Meador Journal: Epilepsy Behav Date: 2012-06-29 Impact factor: 2.937
Authors: Areti Angeliki Veroniki; Elise Cogo; Patricia Rios; Sharon E Straus; Yaron Finkelstein; Ryan Kealey; Emily Reynen; Charlene Soobiah; Kednapa Thavorn; Brian Hutton; Brenda R Hemmelgarn; Fatemeh Yazdi; Jennifer D'Souza; Heather MacDonald; Andrea C Tricco Journal: BMC Med Date: 2017-05-05 Impact factor: 8.775